Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism LTA4H inhibitors(Leukotriene A-4 hydrolase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization Alkahest, Inc.Startup |
Active Organization Alkahest, Inc.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H23NO4 |
InChIKeyMUKBVXXQQUJGNF-HXUWFJFHSA-N |
CAS Registry1400796-47-5 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Alzheimer Disease | Preclinical | US | Alkahest, Inc.Startup | 17 Nov 2023 |
disorder of aging | Preclinical | US | Alkahest, Inc.Startup | 17 Nov 2023 |